Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06967233) titled 'Multimodal Managements for Metastatic Pancreatic Cancer' on May 2.

Study Type: Observational

Primary Sponsor: Zhejiang University

Condition: Metastatic Pancreatic Cancer

Intervention: Other: Multimodal treatment...

Recruitment Status: Not recruiting

Date of First Enrollment: June 1, 2019

Target Sample Size: 360

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT06967233

Published by HT Digital Content Services with permission from Health Daily Digest....